Ko Wing-man

As US-China pharma rivalry heats up, can Hong Kong’s US$8b fund be the global bridge?

AdvertisementChina’s private sectorBusinessChina Business As US-China pharma rivalry heats up, can Hong Kong’s US$8b fund be the global bridge? Hong…